Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Operations: 2009-2024

Historic Cash from Operations for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $517.9 million.

  • Select Medical Holdings' Cash from Operations fell 312.87% to $175.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.7 million, marking a year-over-year decrease of 1444.64%. This contributed to the annual value of $517.9 million for FY2024, which is 1102.88% down from last year.
  • Latest data reveals that Select Medical Holdings reported Cash from Operations of $517.9 million as of FY2024, which was down 1102.88% from $582.1 million recorded in FY2023.
  • Over the past 5 years, Select Medical Holdings' Cash from Operations peaked at $1.0 billion during FY2020, and registered a low of $284.8 million during FY2022.
  • Its 5-year average for Cash from Operations is $562.8 million, with a median of $517.9 million in 2024.
  • Its Cash from Operations has fluctuated over the past 5 years, first surged by 13093.32% in 2020, then crashed by 6097.28% in 2021.
  • Annual analysis of 5 years shows Select Medical Holdings' Cash from Operations stood at $1.0 billion in 2020, then tumbled by 60.97% to $401.2 million in 2021, then dropped by 29.01% to $284.8 million in 2022, then soared by 104.36% to $582.1 million in 2023, then fell by 11.03% to $517.9 million in 2024.
  • Its Cash from Operations stands at $517.9 million for FY2024, versus $582.1 million for FY2023 and $284.8 million for FY2022.